The Effect of Doxorubicin on Viability and Morphology of Human Embryonic Stem Cell-derived Cardiomyocytes
Year: 2014
Type: article
Abstract: In spite of serious cardiotoxicity side-effects, doxorubicin is frequently used for treatment of several types of cancers. Isolated human adult cardiomyocytes could be the best model for assessing drug-induced cardiotoxicity, while harvesting mature cardiomyocytes is restricted by some limitations such as biopsy size, cell numbers, viability, proliferative capacity and theirdisability to be passaged as a cell line. In the present study, human embryonic stem cell (hESC)- derived cardiomyocytes applied as a model for evaluation of doxorubicin cardiotoxicity. In this process, cardiogenic differentiated hESCs spheroids were exposed to different concentrations of doxorubicin for 24, 48 and 72 hours. The viability of spheroids as well as their morphology was assessed as important criterion of cardiotoxicity. Findings of the study showed that the viability ofspheroids was significantly reduced at doses of 3 and 30 μM (P<0.05). Moreover, cell morphology was changed in the presence of same doses. Overall hESC-derived cardiomyocytes (hESC-CMs) could be a useful in vitro model for evaluating drug-induced toxicity.
Source: Journal of chemical health risks
Authors: Marziyeh Shalchi Tousi, Houri Sepehri
Institution: University of Tehran
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: Royan Institute
OpenAlex ID: W1557521710
